Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Interventional
×
isoquercitrin
×
Gastrointestinal
×
Clear all
Filters
3
NCT06861088
2026-02-02
CATIQ P3
Quercis Pharma AG
Phase 3
Recruiting
480 enrolled
NCT02195232
2021-03-03
CATIQ
Dana-Farber Cancer Institute
Phase 2/3
Completed
64 enrolled
7 charts